Complement in human disease: approved and up-and-coming therapeutics

EE West, T Woodruff, V Fremeaux-Bacchi, C Kemper - The Lancet, 2024 - thelancet.com
The complement system is recognised as a protector against blood-borne pathogens and a
controller of immune system and tissue homoeostasis. However, dysregulated complement …

The good, the bad, and the opportunities of the complement system in neurodegenerative disease

ND Schartz, AJ Tenner - Journal of Neuroinflammation, 2020 - Springer
The complement cascade is a critical effector mechanism of the innate immune system that
contributes to the rapid clearance of pathogens and dead or dying cells, as well as …

Clinical promise of next-generation complement therapeutics

DC Mastellos, D Ricklin, JD Lambris - Nature reviews Drug discovery, 2019 - nature.com
The complement system plays a key role in pathogen immunosurveillance and tissue
homeostasis. However, subversion of its tight regulatory control can fuel a vicious cycle of …

Complement in neurological disorders and emerging complement-targeted therapeutics

MC Dalakas, H Alexopoulos, PJ Spaeth - Nature Reviews Neurology, 2020 - nature.com
The complement system consists of a network of plasma and membrane proteins that
modulate tissue homeostasis and contribute to immune surveillance by interacting with the …

Complement in the brain: contributions to neuroprotection, neuronal plasticity, and neuroinflammation

SS Bohlson, AJ Tenner - Annual Review of Immunology, 2023 - annualreviews.org
The complement system is an ancient collection of proteolytic cascades with well-described
roles in regulation of innate and adaptive immunity. With the convergence of a revolution in …

Therapeutic targeting of the complement system: from rare diseases to pandemics

P Garred, AJ Tenner, TE Mollnes - Pharmacological reviews, 2021 - Elsevier
The complement system was discovered at the end of the 19th century as a heat-labile
plasma component that “complemented” the antibodies in killing microbes, hence the name …

Role of neuroinflammation in amyotrophic lateral sclerosis: cellular mechanisms and therapeutic implications

J Liu, F Wang - Frontiers in immunology, 2017 - frontiersin.org
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects
upper motor neurons (MNs) comprising the corticospinal tract and lower MNs arising from …

[HTML][HTML] The complement system, aging, and aging-related diseases

R Zheng, Y Zhang, K Zhang, Y Yuan, S Jia… - International Journal of …, 2022 - mdpi.com
The complement system is a part of the immune system and consists of multiple complement
components with biological functions such as defense against pathogens and …

The microglial NLRP3 inflammasome is activated by amyotrophic lateral sclerosis proteins

V Deora, JD Lee, EA Albornoz, L McAlary, CJ Jagaraj… - Glia, 2020 - Wiley Online Library
Microglial NLRP3 inflammasome activation is emerging as a key contributor to
neuroinflammation during neurodegeneration. Pathogenic protein aggregates such as β …

Therapeutic inhibition of the complement system in diseases of the central nervous system

SM Carpanini, M Torvell, BP Morgan - Frontiers in immunology, 2019 - frontiersin.org
The complement system plays critical roles in development, homeostasis, and regeneration
in the central nervous system (CNS) throughout life; however, complement dysregulation in …